RxDoctor Payments Data

Daphne Cates, MD

Family Medicine · Sanford, NCNPI 1164429205

Payments from drug & device makers

$336in general payments, 2019–2025

Across 19 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$127
  • Abbott$49
  • Pfizer$48
  • Novo Nordisk$32
  • Hologic Sales And Service, LLC$25
  • Bayer$21
  • plus $34 from 2 others

What the payments were for

  • Food & beverage$336100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)7$127
Abbott3$49
Pfizer3$48
Novo Nordisk2$32
Hologic Sales And Service, LLC1$25
Bayer1$21
Novartis1$19
Amgen1$15

How this compares

$336 in reported general payments places this provider in the 50th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$3,460
Medicare patients
85
Services billed
435

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide113$188,839
JardianceEmpagliflozin102$108,767
MounjaroTirzepatide60$64,895
FarxigaDapagliflozin Propanediol65$64,607
TrulicityDulaglutide28$53,667
ProliaDenosumab15$26,535
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$24,844
JanuviaSitagliptin Phosphate16$20,724
JanumetSitagliptin Phos/Metformin Hcl13$15,152
MyrbetriqMirabegron19$12,698
GemtesaVibegron23$11,746
Tresiba Flextouch U-100Insulin Degludec17$11,480
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$5,628
Humalog Kwikpen U-100Insulin Lispro12$4,336
SymbicortBudesonide/Formoterol Fumarate15$3,880

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$32$188,839113 claims
AmgenProlia$15$26,53515 claims
AbbVieSynthroid$127$2,13517 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Sanford

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →